This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Greenberg, B. et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet 10.1016/S0140-6736(16)00082-9
Rights and permissions
About this article
Cite this article
Fernàndez-Ruiz, I. No improvement in outcomes with gene therapy for heart failure. Nat Rev Cardiol 13, 122–123 (2016). https://doi.org/10.1038/nrcardio.2016.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2016.14